# FDA Inspection 1032345 - Novo Nordisk Pharmaceuticals Co. Ltd - November 02, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmaceuticals-co-ltd/09c3e838-7ea0-4df5-9c0d-2830b2de61ce
Source feed: FDA_Inspections

> FDA Inspection 1032345 for Novo Nordisk Pharmaceuticals Co. Ltd on November 02, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1032345
- Company Name: Novo Nordisk Pharmaceuticals Co. Ltd
- Inspection Date: 2017-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1032345 - 2017-11-02](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmaceuticals-co-ltd/00de4dfb-21a5-41e3-b38f-273f0e5daac5)
- [FDA Inspection 636133 - 2009-11-18](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmaceuticals-co-ltd/9379136f-3e24-4edc-9eec-e2d7cb4c7dc6)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-pharmaceuticals-co-ltd/0473e12a-d9b2-4209-9e15-f7af60b5209d

Office: https://www.globalkeysolutions.net/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7